Old Web
English
Sign In
Acemap
>
authorDetail
>
Karin Barchan
Karin Barchan
Antibody
Cancer research
Medicine
Mutagenesis
Molecular biology
4
Papers
55
Citations
0.00
KQI
Citation Trend
Filter By
Interval:
1900~2024
1900
2024
Author
Papers (4)
Sort By
Default
Most Recent
Most Early
Most Citation
No data
Journal
Conference
Others
The CTLA-4 x OX40 bispecific antibody ATOR-1015 induces anti-tumor effects through tumor-directed immune activation
2019
Journal for ImmunoTherapy of Cancer
Anne Månsson-Kvarnhammar
Niina Veitonmäki
Karin Hägerbrand
Anna Dahlman
Karin Enell Smith
Sara Fritzell
Laura von Schantz
Mia Thagesson
Doreen Werchau
Kristine Smedenfors
Maria Johansson
Anna Rosén
Ida Åberg
Magnus Winnerstam
Eva Nyblom
Karin Barchan
Christina Furebring
Per Norlén
Peter Ellmark
Show All
Source
Cite
Save
Citations (40)
Abstract A183: ATOR-1017: A 4-1BB antibody designed for superior safety/efficacy profile in cancer immunotherapy
2019
Cancer immunology research
Eva Dahlén
Anna Rosén
Karin Barchan
Anna Dahlman
Peter Ellmark
Tina Furebring
Karin Enell Smith
Show All
Source
Cite
Save
Citations (0)
Directed evolution of chemotaxis inhibitory protein of Staphylococcus aureus generates biologically functional variants with reduced interaction with human antibodies
2010
Protein Engineering Design & Selection
Erika Gustafsson
Anna Rosén
Karin Barchan
Kok P. M. van Kessel
Karin Haraldsson
Stina Lindman
Cecilia Forsberg
Lill Ljung
Karin Bryder
Björn Walse
Pieter-Jan Haas
Jos A. G. van Strijp
Christina Furebring
Show All
Source
Cite
Save
Citations (10)
Development of Interleukin-1 Receptor Antagonist Mutants with Enhanced Antagonistic Activity In Vitro and Improved Therapeutic Efficacy in Collagen-Induced Arthritis
2008
Journal of Immunotoxicology
Eva Maria Dahlén
Karin Barchan
Daniel Herrlander
Patrik Höjman
Marie Karlsson
Lill Ljung
Mats Andersson
Eva Backman
Ann-Christin Malmborg Hager
Björn Walse
Leo A. B. Joosten
Wim B. van den Berg
Show All
Source
Cite
Save
Citations (5)
1